Cargando…

Chemoradiation versus oesophagectomy for locally advanced oesophageal cancer in Chinese patients: study protocol for a randomised controlled trial

BACKGROUND: Surgery is the gold standard treatment for local advanced disease, while definitive concurrent chemoradiotherapy (DCRT) is recommended for those who are medically unable to tolerate major surgery or medically fit patients who decline surgery. The primary aim of this trial is to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ruinuo, Yin, Weijiao, Li, Shuoguo, Li, Ruonan, Yang, Junqiang, Shan, Tanyou, Zhou, Dan, Wang, Wei, Wan, Lixin, Zhou, Fuyou, Gao, Shegan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458742/ https://www.ncbi.nlm.nih.gov/pubmed/30971301 http://dx.doi.org/10.1186/s13063-019-3316-5

Ejemplares similares

Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer
por: Gao, Shegan, et al.
Publicado: (2016)

Laparoscopically assisted versus open oesophagectomy for patients with oesophageal cancer—the Randomised Oesophagectomy: Minimally Invasive or Open (ROMIO) study: protocol for a randomised controlled trial (RCT)
por: Brierley, Rachel C, et al.
Publicado: (2019)

Expression of serum- and glucocorticoid-regulated kinase 1 and its association with clinicopathological factors and the survival of patients with adenocarcinoma of the esophagogastric junction
por: Gao, Shegan, et al.
Publicado: (2017)

Learning curve for minimally invasive oesophagectomy of oesophageal cancer and survival analysis
por: Zhao, Yunpeng, et al.
Publicado: (2021)

Impact of postoperative complications on survival after oesophagectomy for oesophageal cancer
por: Bundred, J. R., et al.
Publicado: (2020)

GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation
por: Jia, Ruinuo, et al.
Publicado: (2019)

Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial
por: Mu, Juwei, et al.
Publicado: (2015)

Diaphragmatic hernia following oesophagectomy for oesophageal cancer – Are we too radical?
por: Argenti, F., et al.
Publicado: (2016)

Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy
por: Knight, W. R. C., et al.
Publicado: (2018)

A computationally constructed ceRNA interaction network based on a comparison of the SHEE and SHEEC cell lines
por: Sun, Jiachun, et al.
Publicado: (2016)

Corrigendum to “KDM4C, a H3K9me3 histone demethylase, is involved in the maintenance of human ESCC-initiating cells by epigenetically enhancing SOX2 expression” [Neoplasia 18 (2016) 594-609]
por: Yuan, Xiang, et al.
Publicado: (2016)

KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression()
por: Yuan, Xiang, et al.
Publicado: (2016)

Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score
por: Ubels, Sander, et al.
Publicado: (2022)

Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis
por: Zhou, Can, et al.
Publicado: (2015)

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial
por: Briez, Nicolas, et al.
Publicado: (2011)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2015)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Chemoradiation for oesophageal cancer: the choice of treatment modality
por: Kitti, Pauliina M., et al.
Publicado: (2023)

Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial
por: Klotz, Rosa, et al.
Publicado: (2023)

Minithoracotomy oesophagectomy for oesophageal carcinoma with aberrant right subclavian artery: a rare case of dysphagia
por: Subasinghe, Duminda, et al.
Publicado: (2014)

Minimally invasive techniques for transthoracic oesophagectomy for oesophageal cancer: systematic review and network meta‐analysis
por: Siaw‐Acheampong, K., et al.
Publicado: (2020)

Outcome of microscopically non-radical oesophagectomy for oesophageal and oesophagogastric junctional cancer: nationwide cohort study
por: Hollertz, P, et al.
Publicado: (2021)

Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial
por: Parekh, Dhruv, et al.
Publicado: (2013)

Combined modality chemoradiation in elderly oesophageal cancer patients
por: Anderson, S E, et al.
Publicado: (2007)

Robotic-assisted single-incision gastric mobilization for minimally invasive oesophagectomy for oesophageal cancer: preliminary results
por: Huang, Yu-Han, et al.
Publicado: (2020)

Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study
por: Ubels, Sander, et al.
Publicado: (2023)

Drainless robot-assisted minimally invasive oesophagectomy—randomized controlled trial (RESPECT)
por: Müssle, B., et al.
Publicado: (2023)

Efficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials
por: Yin, Weijiao, et al.
Publicado: (2015)

Molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Ajani, J A
Publicado: (2008)

Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007)

Outcomes following oesophagectomy in patients with oesophageal cancer: a secondary analysis of the ICNARC Case Mix Programme Database
por: Park, Daniel P, et al.
Publicado: (2009)

Right versus left thoracic approach oesophagectomy for oesophageal cancer: a systematic review and meta-analysis protocol
por: Chai, Tianci, et al.
Publicado: (2019)

Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival
por: Kauppila, Joonas H., et al.
Publicado: (2017)

Severe weight loss after minimally invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer at 5 years
por: Koterazawa, Yasufumi, et al.
Publicado: (2020)

Advantages of McKeown minimally invasive oesophagectomy for the treatment of oesophageal cancer: propensity score matching analysis of 169 cases
por: Xie, Jun, et al.
Publicado: (2022)

Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Yoshikawa, R, et al.
Publicado: (2008)

Surgical treatment of the severe thoracic gastrocutaneous fistula by pedicled muscle flap filling and thoracoplasty after oesophagectomy for oesophageal squamous cell carcinoma: A case report
por: Yu, Dongmin, et al.
Publicado: (2019)

Minimally invasive oesophagectomy: The first case report of a thoracolaparoscopic oesophagectomy done in the Caribbean
por: Singh, Yardesh, et al.
Publicado: (2020)

GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial
por: Jia, Ruinuo, et al.
Publicado: (2020)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d5oa4clnrfnnepi6j5as44mvhj